ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS) following switch to Kesimpta after ...
ALUULA delivers on broader market growth and announces leadership changeVictoria, British Columbia--(Newsfile Corp. - September 23, 2025) - ALUULA Composites Inc. (TSXV: AUUA) ("ALUULA" or the ...
Abstract: This paper presents a joint trajectory smoothing and tracking framework for a specific class of targets with smooth motion. We model the target trajectory by a continuous function of time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback